Serum and erythrocyte adenosine deaminase activities in patients with Behçet's disease

Int J Dermatol. 2006 Sep;45(9):1053-6. doi: 10.1111/j.1365-4632.2006.02892.x.

Abstract

Objectives: Adenosine deaminase (ADA) is a non-specific marker of the activation of the T cell, which has an important role in the etiology of Behçet's disease (BD). The purpose of this study was to investigate the determination of ADA activity as an index of T-lymphocyte function in BD, which is known to have an T-cell-mediated immune response.

Materials and methods: Adenosine deaminase activities in both serum and erythrocytes were measured in 23 untreated patients with BD and in 20 healthy controls. The patients with BD were divided into two groups: active (n = 10) and inactive (n = 13).

Results: When compared with the control group, serum ADA activity was high (P < 0.01) and erythrocyte ADA activity was significantly low (P < 0.01) in BD. Serum ADA activity of active BD was higher than that of inactive BD (P < 0.01), but erythrocyte ADA activity was found to be lower in active BD than inactive BD (P < 0.01).

Comment: These findings may provide an additional benefit for the diagnosis of BD and sub-typing of active and inactive BD.

Publication types

  • Comparative Study

MeSH terms

  • Adenosine Deaminase / blood*
  • Adolescent
  • Adult
  • Behcet Syndrome / blood*
  • Behcet Syndrome / diagnosis
  • Behcet Syndrome / enzymology
  • Biomarkers / blood
  • Erythrocytes / cytology
  • Erythrocytes / enzymology*
  • Female
  • Humans
  • Male
  • Middle Aged

Substances

  • Biomarkers
  • Adenosine Deaminase